In the Genomics of Drug Sensitivity in Cancer (GDSC) database, part of the 3q26 locus, including SOX2 and DCUN1D1 genes, is identified as a recurrent copy-number alteration in the pan-cancer analysis (feature cnaPANCAN246 in the database). This evidence concerns the gene SOX2 and cancer.